Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.

Ni HJ, Chang YN, Kao PH, Chai SP, Hsieh YH, Wang DH, Fong JC.

Biochim Biophys Acta. 2012 Dec;1820(12):1893-900. doi: 10.1016/j.bbagen.2012.08.002. Epub 2012 Aug 10.

PMID:
22906975
2.

Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.

Wang Z, Hu H, Li G, Lee HJ, Jiang C, Kim SH, Lü J.

Int J Cancer. 2008 Jan 1;122(1):15-24.

3.

Cyclin E-CDK2 protein phosphorylates plant homeodomain finger protein 8 (PHF8) and regulates its function in the cell cycle.

Sun L, Huang Y, Wei Q, Tong X, Cai R, Nalepa G, Ye X.

J Biol Chem. 2015 Feb 13;290(7):4075-85. doi: 10.1074/jbc.M114.602532. Epub 2014 Dec 29.

5.

CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.

Teixeira C, Pratt MA.

Mol Endocrinol. 1997 Aug;11(9):1191-202.

PMID:
9259311
7.

Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation.

Liu Q, Liu X, Gao J, Shi X, Hu X, Wang S, Luo Y.

Int J Biol Sci. 2013 Jun 9;9(6):541-9. doi: 10.7150/ijbs.5763. Print 2013.

8.
9.
10.

Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).

Wei M, Liu B, Gu Q, Su L, Yu Y, Zhu Z.

Cell Oncol (Dordr). 2013 Feb;36(1):79-93. doi: 10.1007/s13402-012-0115-3. Epub 2012 Nov 27.

PMID:
23184467
11.
12.

Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset.

Yuan X, Srividhya J, De Luca T, Lee JH, Pomerening JR.

Mol Biol Cell. 2014 Feb;25(4):441-56. doi: 10.1091/mbc.E13-08-0480. Epub 2013 Dec 19.

13.

Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.

Rodríguez-Ubreva FJ, Cariaga-Martinez AE, Cortés MA, Romero-De Pablos M, Ropero S, López-Ruiz P, Colás B.

Oncogene. 2010 Jan 21;29(3):345-55. doi: 10.1038/onc.2009.329. Epub 2009 Oct 19.

PMID:
19838216
15.

Effects of cyclin D1 overexpression on G1 progression-related events.

Imoto M, Doki Y, Jiang W, Han EK, Weinstein IB.

Exp Cell Res. 1997 Oct 10;236(1):173-80.

PMID:
9344597
17.

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).

Greeve MA, Allan RK, Harvey JM, Bentel JM.

J Mol Endocrinol. 2004 Jun;32(3):793-810.

PMID:
15171713
18.

p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.

Smartt HJ, Guilmeau S, Nasser SV, Nicholas C, Bancroft L, Simpson SA, Yeh N, Yang W, Mariadason JM, Koff A, Augenlicht LH.

Gastroenterology. 2007 Jul;133(1):232-43. Epub 2007 Apr 25.

PMID:
17631145
20.

Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.

Le XF, Bedrosian I, Mao W, Murray M, Lu Z, Keyomarsi K, Lee MH, Zhao J, Bast RC Jr.

Cell Cycle. 2006 Aug;5(15):1654-61. Epub 2006 Aug 1.

PMID:
16861913

Supplemental Content

Support Center